- Home
- GTE vs LYEL Comparison
GTE vs LYEL Comparison
Compare GTE & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTE
- LYEL
- Stock Information
- Founded
- GTE 2003
- LYEL 2018
- Country
- GTE Canada
- LYEL United States
- Employees
- GTE N/A
- LYEL N/A
- Industry
- GTE Oil & Gas Production
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- GTE Energy
- LYEL Health Care
- Exchange
- GTE Nasdaq
- LYEL Nasdaq
- Market Cap
- GTE 178.8M
- LYEL 207.7M
- IPO Year
- GTE N/A
- LYEL 2021
- Fundamental
- Price
- GTE $4.92
- LYEL $9.43
- Analyst Decision
- GTE
- LYEL Sell
- Analyst Count
- GTE 0
- LYEL 2
- Target Price
- GTE N/A
- LYEL $15.00
- AVG Volume (30 Days)
- GTE 352.1K
- LYEL 311.0K
- Earning Date
- GTE 07-30-2025
- LYEL 08-06-2025
- Dividend Yield
- GTE N/A
- LYEL N/A
- EPS Growth
- GTE N/A
- LYEL N/A
- EPS
- GTE N/A
- LYEL N/A
- Revenue
- GTE $634,805,000.00
- LYEL $65,000.00
- Revenue This Year
- GTE $11.42
- LYEL N/A
- Revenue Next Year
- GTE N/A
- LYEL N/A
- P/E Ratio
- GTE N/A
- LYEL N/A
- Revenue Growth
- GTE N/A
- LYEL N/A
- 52 Week Low
- GTE $3.34
- LYEL $7.65
- 52 Week High
- GTE $10.35
- LYEL $38.40
- Technical
- Relative Strength Index (RSI)
- GTE 46.35
- LYEL 50.01
- Support Level
- GTE $4.92
- LYEL $8.46
- Resistance Level
- GTE $6.29
- LYEL $9.80
- Average True Range (ATR)
- GTE 0.34
- LYEL 0.90
- MACD
- GTE -0.10
- LYEL -0.09
- Stochastic Oscillator
- GTE 13.29
- LYEL 38.80
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.